Learn more about our Advocacy work.
In testimony today before the U.S. House of Representatives Committee on Small Business, Dr. Lishan Aklog urged Congress and the executive branch to consider the dire consequences for patients and…
Today, AdvaMed, The Medtech Association®, announced Kelvyn Cullimore, President and CEO of BioUtah, will serve as the next chair of the State Medtech Alliance (SMTA). The Alliance is a consortium…
The on-field cardiac arrest of football player Damar Hamlin raised the profile of automatic external defibrillators (AEDs). An AED helped save his life.
AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker upon the passage of a research and development expensing tax provision critical to medtech innovation in the…
Scott Whitaker, president and CEO of AdvaMed, The Medtech Association®, today urged Congress to enact a research and development expensing tax provision critical to medtech innovation. The provision would delay…
In a new op-ed in RealClear Health, AdvaMed® President and CEO Scott Whitaker called on the Biden Administration to ensure the medtech industry is considered as it implements policies to…
Today, diabetes was front and center during a Senate HELP Committee hearing, prompting AdvaMed® President and CEO Scott Whitaker to release the following statement on the ways life-saving medical technology…
Today, AdvaMedDx® submitted comments in response to the Food and Drug Administration’s Proposed Rule: Medical Devices; Laboratory Developed Tests. AdvaMedDx® is a division of AdvaMed® representing companies that develop in…
Today, AdvaMed® President and CEO Scott Whitaker released the following statement upon House passage of The Prematurity Research Expansion and Education for Mothers who deliver Infants Early (PREEMIE) Reauthorization Act:
In testimony today before a key congressional subcommittee hearing, AdvaMed, The Medtech Association®, called for a balance in the proposed regulations of the method used to sterilize 20 billion, or…